13 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... LAMA: long-acting ... #Management #Pulmonary ... #LABA #ICS #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... -agonist; LAMA, ... #Algorithm #Management ... #Pulmonary #LABA ... #LAMA #SABA #SAMA
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
ICS: inhaled corticosteroids ... receptor antagonists; LABA ... : long-acting β2 ... #GINA #Asthma #Management ... #Stepwise #Pulmonary
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
summary of the differential ... asthma-COPD overlap; ICS ... -agonist; LAMA = ... #Diagnosis #Management ... Differences #Algorithm #Treatment
Hyperacute Hypoxemia - Workup and Management
Differential Diagnosis: Aspiration, Flash Pulmonary Edema, Mucous Plugging, Bronchospasm, Pulmonary Embolism,
Differential Diagnosis ... Bronchospasm, Pulmonary ... (JVP, edema), Lung ... POCUS (B-lines, lung ... #treatment #criticalcare
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... Clindamycin in case of PCN ... Abscess Differential ... #Abscess #pulmonary ... #differential #
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Imaging: CXR- pulmonary ... initiation • Differential ... organ dysfuxtion, ICU ... fluid overload, PCC ... APML #diagnosis #management
Incidental Finding of Oleothorax - A chest radiograph showed a dense opacity in the upper area
The differential ... her history of treatment ... oleothorax — a treatment ... for pulmonary tuberculosis ... #Clinical #PCC #
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
staining, NAA (PCR ... Tuberculosis Treatment ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
staining, NAA (PCR ... Tuberculosis Treatment ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB